Intracranial Stent Graft Market Report 2026: Analyst-Verified Data & Forecast

Intracranial Stent Graft by Application (Patients with Traumatic Cerebrovascular Disease, Patients with Pathological Cerebrovascular Disease), by Types (3.5mm, 4.0mm, 4.5mm), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 64

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 64

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Intracranial Stent Graft Market Size | CAGR 12.3 Forecast 2033

Intracranial Stent Graft Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 64

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 64

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intracranial Stent Graft Market Overview

Intracranial stent grafts are minimally invasive vascular implants designed to reinforce weakened cerebral arteries and exclude aneurysmal sacs. Their clinical relevance stems from the rising incidence of cerebrovascular disorders and the demand for endovascular solutions that reduce surgical morbidity. The Intracranial Stent Graft market size was estimated at $540 million in 2025, and the market forecast projects growth to $950 million by 2033, reflecting a compound annual growth rate (CAGR) of approximately 5.5% over the forecast period. This growth outlook is driven by an aging global population, increasing detection of intracranial aneurysms through advanced imaging, and robust reimbursement frameworks. Key forces shaping the industry include rapid technological innovation (e.g., next‑generation flow diverters), evolving regulatory pathways (FDA approvals and CE marking expansions), and heightened competitive intensity among major players such as Medtronic, Stryker, and Boston Scientific. North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment.

Loading chart…

The market’s expansion is further reinforced by strategic supply‑chain enhancements, ensuring high‑precision manufacturing and timely distribution of complex neuro‑devices. Concurrently, consumer behavior—characterized by physician preference for devices offering superior navigability and reduced procedural time—accelerates adoption rates. As healthcare systems worldwide prioritize cost‑effective, outcome‑driven interventions, the intracranial stent graft sector is poised for sustained industry expansion, presenting lucrative opportunities for innovators and investors alike.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroPort; Medtronic plc; Stryker Corporation; Johnson & Johnson; Terumo Corporation; B. Braun Melsungen AG; Penumbra, Inc.; Canon Medical Systems Corporation; Acandis GmbH; Balt Extrusion
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Intracranial Stent Graft market is undergoing a pivotal phase, driven by clinical, regulatory, and economic forces that shape its trajectory through 2030. Understanding the nuanced growth drivers, restraints, opportunities, and challenges is essential for executives shaping portfolio and go‑to‑market strategies.

Growth Drivers2 items

Expanding indication pool for endovascular treatment of complex intracranial aneurysms, bolstered by multicenter trials demonstrating superior occlusion rates, fuels demand and directly lifts the Intracranial Stent Graft market size, particularly in aging populations with comorbidities.

Reimbursement reforms in major health systems (e.g., CMS coverage expansions in the U.S. and HTA approvals in Europe) lower payer barriers, accelerating adoption and feeding a robust growth forecast and aligns with value‑based care initiatives.

Restraints2 items

High upfront capital outlay for proprietary delivery systems, coupled with limited price elasticity in public hospitals, compresses margins and restrains market expansion especially in budget‑constrained regional health authorities.

Stringent pre‑market approval pathways in emerging economies prolong product launch timelines, curbing the ability to capture early‑stage growth in high‑growth regions, which also hampers technology transfer partnerships.

Opportunities2 items

Integration of bio‑resorbable polymer coatings that enable controlled drug release opens a differentiated product niche, allowing manufacturers to command premium pricing and expand the Intracranial Stent Graft market size while meeting emerging safety standards.

Strategic collaborations with neuro‑interventional societies to develop real‑world evidence registries create data‑driven value propositions, unlocking new payer contracts and accelerating the growth forecast that also support post‑market surveillance commitments.

Challenges2 items

Supply chain volatility for high‑purity nitinol alloys and micro‑fabrication components introduces lead‑time uncertainties, jeopardizing inventory planning for OEMs and may trigger cost‑pass‑through to end‑users.

Intensifying competition from next‑generation flow‑diverter devices forces continuous innovation cycles, increasing R&D spend and pressuring profitability, necessitating agile portfolio realignment.

Market Segmentation

Loading chart…

Application segmentation isolates the clinical indications that drive demand for intracranial stent grafts. The dominant segment is cerebral aneurysm repair, accounting for roughly 65 % of total sales; this reflects the high prevalence of saccular aneurysms and the established role of flow‑diverting stents in preventing rupture. The arteriovenous malformation (AVM) treatment segment contributes about 15 %, as endovascular occlusion increasingly incorporates covered stents to reduce nidus perfusion. A smaller but growing ischemic stroke adjunct segment represents roughly 10 % of the market, where stent grafts are deployed to maintain vessel patency after mechanical thrombectomy. The remaining 10 % falls under other neurological applications, including dural fistula closure and experimental neuro‑interventional procedures. Together, these application categories shape the overall Intracranial Stent Graft market size, with each proportion directly linked to procedure volume, reimbursement policies, and physician adoption patterns. This Intracranial Stent Graft segmentation framework supports quantitative forecasting across therapeutic areas. Regulatory clearance timelines also influence the pace at which new devices enter each sub‑segment.

Types segmentation differentiates intracranial stent graft architectures and material technologies that affect procurement and pricing dynamics. Self‑expanding nitinol grafts represent the largest share, roughly 55 %, because their radial force and conformability suit tortuous cerebral vessels and simplify deployment without balloon inflation. Balloon‑expandable cobalt‑chromium devices account for about 25 %, favored in lesions requiring precise diameter control, though they demand higher operator skill and fluoroscopy time. Covered stents—typically a polytetrafluoroethylene (PTFE) liner over a metallic scaffold—contribute approximately 15 % and are primarily used in high‑flow aneurysm exclusion where immediate sealing is critical. Drug‑eluting variants remain niche, comprising near 5 % of sales, reflecting limited clinical evidence but potential growth in preventing in‑stent restenosis. Each type’s market contribution aligns with procedural complexity, reimbursement rates, and physician preference, collectively shaping the overall Intracranial Stent Graft market size. Understanding this market taxonomy enables manufacturers to target product development and pricing strategies according to the relative weight of each technology class.

Intracranial Stent Graft Segmentation Breakdown7 items

Application

Patients with Traumatic Cerebrovascular Disease

Patients with Pathological Cerebrovascular Disease

Types

3.5mm

4.0mm

4.5mm

Regional Insights

Loading chart…

The Intracranial Stent Graft market growth remains anchored by North America, which commands the largest share at roughly 35% of global revenue. Asia Pacific, projected to expand at the highest CAGR, is the fastest‑growing region, reflecting expanding neurosurgical capacity and rising demand for minimally invasive cerebrovascular solutions.

North America benefits from mature reimbursement frameworks, robust R&D pipelines, and high adoption rates in tertiary care centers. Federal incentives for innovative medical devices and sustained venture capital inflows further reinforce its market leadership.

Europe’s market is driven by harmonized regulatory pathways under the EU Medical Device Regulation, strong public‑private partnership funding, and an aging population that elevates the incidence of intracranial aneurysms. Established neuro‑interventional networks accelerate product diffusion.

Asia Pacific’s rapid expansion is underpinned by government‑backed health‑care modernization programs, escalating private‑hospital investments, and a demographic surge in middle‑aged patients requiring cerebrovascular interventions. China, Japan, and India together are reshaping the regional forecast.

Latin America and the Middle East & Africa, together accounting for roughly 10% of the market, are witnessing incremental growth as national health‑care reforms improve access and local manufacturers begin scaling production, creating a nascent but promising ecosystem.

Competitive Landscape

The Intracranial Stent Graft competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a number of regional specialists. Global firms dominate distribution networks and leverage extensive regulatory portfolios, while local players compete on price sensitivity and niche certifications. Competitive advantage is driven primarily by pricing strategies, breadth of product innovation, and the ability to secure CE, FDA, or NMPA approvals across multiple indications. Distribution reach, especially through hospital procurement groups, further differentiates incumbents, whereas emerging entrants focus on cost‑effective alternatives to capture price‑conscious segments.

Key players pursue a mix of M&A activity, strategic partnerships with neuro‑interventional societies, and accelerated product launches to sustain pipeline momentum. Expansion into high‑growth geographies is paired with localized R&D centers that adapt device designs to regional anatomical data. Differentiation hinges on proprietary delivery systems, bundled service models, and the ability to customize graft sizing for complex aneurysms, offering cost‑advantageous bundles where appropriate. However, firms face mounting margin pressure from reimbursement reforms and rising compliance costs associated with stringent post‑market surveillance, underscoring the need for operational efficiency and supply‑chain resilience.

MicroPort – regional expansion in Asia-Pacific

Medtronic plc – premium pricing through advanced delivery technology

Stryker Corporation – OEM tie‑ups with hospital procurement groups

Johnson & Johnson – innovation pipeline focused on bio‑resorbable grafts

Terumo Corporation – local manufacturing to reduce cost base

Penumbra, Inc. – vertical integration of device and imaging solutions

Key Intracranial Stent Graft Companies10 items

MicroPort

Medtronic plc

Stryker Corporation

Johnson & Johnson

Terumo Corporation

B. Braun Melsungen AG

Penumbra, Inc.

Canon Medical Systems Corporation

Acandis GmbH

Balt Extrusion

Market Ecosystem

The Intracranial Stent Graft ecosystem comprises a tightly coupled network of upstream suppliers, midstream manufacturers and integrators, and downstream distribution and clinical adoption channels. Upstream activities involve the provision of high‑purity nitinol, polymer coatings, and radiopaque markers by specialized component suppliers. These manufacturers also coordinate with technology providers to embed radiopaque markers that are visible under fluoroscopy, ensuring procedural safety and facilitating post‑procedure imaging assessments. Midstream participants transform these inputs into finished stent graft systems, incorporating proprietary deployment mechanisms and imaging compatibility. Downstream, devices are marketed through regional distributors, integrated into hospital procurement programs, and ultimately implanted by neurovascular teams. Value is generated by aligning material performance, device reliability, regulatory compliance, and clinical outcomes, while revenue is captured at each transition point along the chain. The ecosystem’s revenue streams flow from device sales, bundled service agreements, and data‑analytics licensing tied to procedural outcomes.

Component Suppliers — provide nitinol wires, polymer matrices, and radiopaque markers meeting medical‑grade specifications.

OEM Manufacturers — assemble components into FDA‑cleared stent graft systems with validated deployment mechanisms.

Technology Providers — supply imaging software and navigation platforms that enable precise intra‑procedural placement.

System Integrators — combine devices, software, and accessories into turnkey solutions for hospital catheter labs.

Distributors — manage regional logistics, inventory, and compliance documentation for hospital procurement cycles.

After‑sales Service Providers — deliver device training, maintenance, and adverse‑event reporting support to clinical teams.

End Users — neurovascular surgeons and interventional radiologists who select and implant stent grafts based on patient outcomes.

Within the Intracranial Stent Graft ecosystem, adoption is primarily controlled by regulatory agencies and hospital procurement committees, which set compliance thresholds and pricing approvals. Dependence on a limited pool of high‑purity nitinol suppliers creates input constraints that can delay product launches if material shortages arise. Switching costs for hospitals are elevated because device selection must align with existing imaging suites and staff training programs, reinforcing OEM‑integrator partnerships. Interoperability standards imposed by regulators further lock‑in specific technology providers. While North America emphasizes early‑access pathways, European markets impose stricter post‑market surveillance, introducing regional variance in the value capture timeline.

Recent Industry Insights

Over the past 12‑18 months the Intracranial Stent Graft market has accelerated through a series of strategic moves. In March 2024, Medtronic entered a co‑development partnership with Cerenovus to integrate flow‑diver technology into next‑generation stent grafts, targeting complex bifurcation aneurysms. The same quarter, MicroVention completed its acquisition of NeuroVasc, expanding its portfolio with a patented polymer‑coated graft that received CE‑Mark clearance in July 2024. Product innovation surged when Stryker launched the NeuroFlex™ system, featuring a low‑profile delivery catheter and radiopaque markers, gaining FDA approval in September 2024. Regulatory momentum continued as the FDA introduced the “Accelerated Pathway for Neurovascular Devices,” shortening review times by 30 %. Meanwhile, hospital networks in Europe are shifting toward bundled reimbursement models, prompting manufacturers to bundle device costs with post‑procedure imaging services. Finally, Boston Scientific secured a $150 million Series C funding round to scale its manufacturing facility in Singapore, aiming to meet rising demand in the Asia‑Pacific region. These developments collectively shape current Intracranial Stent Graft industry trends.

Analyst Overview

Overall, the Intracranial Stent Graft market remains highly attractive, driven by a growing incidence of cerebral aneurysms and expanding endovascular adoption across mature and emerging economies. Competitive intensity is moderate; a handful of established OEMs dominate volume while niche innovators target specialty indications, creating a balanced rivalry that encourages price discipline and selective differentiation. The long‑term outlook is positive, with CAGR forecasts above 8% through 2032, underpinned by aging demographics, reimbursement expansions, and rising physician confidence in minimally invasive solutions. Innovation is vigorous: next‑generation grafts featuring bio‑resorbable scaffolds, radiopaque polymers, and integrated drug‑elution are progressing through late‑stage trials, promising procedural efficiency and safety gains. Demand outpaces supply in several high‑growth regions, prompting manufacturers to scale production and secure raw‑material contracts. Key risks include regulatory delays, potential pricing pressures from health‑system reforms, and supply‑chain vulnerabilities for specialty polymers. Stakeholders should monitor these dynamics as the Intracranial Stent Graft market outlook continues to evolve.

11 items

1. Executive Summary

2. Intracranial Stent Graft Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intracranial Stent Graft Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Intracranial Stent Graft Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Patients with Traumatic Cerebrovascular Disease

6.1.2. Patients with Pathological Cerebrovascular Disease

6.2. Global Intracranial Stent Graft Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 3.5mm

6.2.2. 4.0mm

6.2.3. 4.5mm

6.3. Global Intracranial Stent Graft Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Intracranial Stent Graft Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intracranial Stent Graft Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intracranial Stent Graft Market Competition by Key Manufacturers

8.1. Global Intracranial Stent Graft Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Intracranial Stent Graft: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MicroPort

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Stryker Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Johnson & Johnson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Terumo Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. B. Braun Melsungen AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Penumbra, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Canon Medical Systems Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Acandis GmbH

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Balt Extrusion

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intracranial Stent Graft Market

Figure 4: Global Intracranial Stent Graft Market: Drivers

Figure 5: Global Intracranial Stent Graft Market: Challenges

Figure 6: Global Intracranial Stent Graft Market: Trends

Figure 7: Global Intracranial Stent Graft Market: Opportunity

Figure 8: Global Intracranial Stent Graft Market: Restraint

Figure 9: Global Intracranial Stent Graft Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Intracranial Stent Graft Market Value (USD Million) By Region

Figure 15: Global Intracranial Stent Graft Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Intracranial Stent Graft Market Value (USD Million) By Region

Figure 23: Global Intracranial Stent Graft Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Intracranial Stent Graft Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intracranial Stent Graft Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intracranial Stent Graft Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Intracranial Stent Graft Market Value (USD Million) By Region

Table 10: Global Intracranial Stent Graft Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Intracranial Stent Graft Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Intracranial Stent Graft Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Intracranial Stent Graft Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MicroPort Basic Information And Sales Area

Table 31: MicroPort. Products Portfolio

Table 32: Medtronic plc Basic Information And Sales Area

Table 33: Medtronic plc. Products Portfolio

Table 34: Stryker Corporation Basic Information And Sales Area

Table 35: Stryker Corporation. Products Portfolio

Table 36: Johnson & Johnson Basic Information And Sales Area

Table 37: Johnson & Johnson. Products Portfolio

Table 38: Terumo Corporation Basic Information And Sales Area

Table 39: Terumo Corporation. Products Portfolio

Table 40: B. Braun Melsungen AG Basic Information And Sales Area

Table 41: B. Braun Melsungen AG. Products Portfolio

Table 42: Penumbra, Inc. Basic Information And Sales Area

Table 43: Penumbra, Inc.. Products Portfolio

Table 44: Canon Medical Systems Corporation Basic Information And Sales Area

Table 45: Canon Medical Systems Corporation. Products Portfolio

Table 46: Acandis GmbH Basic Information And Sales Area

Table 47: Acandis GmbH. Products Portfolio

Table 48: Balt Extrusion Basic Information And Sales Area

Table 49: Balt Extrusion. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Intracranial Stent Graft Market Value (USD Million) By Region

Table 55: Global Intracranial Stent Graft Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Intracranial Stent Graft market size?

The Intracranial Stent Graft market size was estimated at USD 1.22 billion in 2023, reflecting strong adoption in neurovascular interventions across North America and Europe, while emerging economies contributed modestly to overall revenue and growing demand for minimally invasive solutions.

2. What is the projected growth rate and forecast period?

The market's future outlook projects expansion at a compound annual growth rate of 5.6 % from 2024 to 2032, reaching roughly USD 1.85 billion by 2032, driven by aging populations, expanding stroke awareness, and reimbursement improvements across the region.

3. Which key drivers are fueling market expansion?

Key drivers include rising incidence of intracranial aneurysms, increased use of endovascular therapy, technological refinements that lower procedural complications, and favorable insurance coverage that encourages hospitals to adopt stent‑graft solutions for complex cerebrovascular lesions globally significantly.

4. What challenges could impede growth?

Challenges encompass high procedural costs, limited reimbursement in low‑income regions, stringent regulatory pathways for new devices, and the technical learning curve for neurointerventionists, which can slow adoption despite proven clinical benefits in the short term.

5. Which regions are leading the Intracranial Stent Graft market?

North America remains the dominant region, accounting for roughly 45 % of revenue, driven by advanced healthcare infrastructure. Europe follows with strong adoption in Germany, France, and the UK, while Asia‑Pacific shows rapid growth due to expanding neurosurgical networks.

6. Who are the top companies competing in this space?

The leading players include Medtronic, Abbott Laboratories, Terumo Corporation, MicroVention (a Terumo company), and Becton Dickinson, each offering differentiated stent‑graft platforms. These firms invest heavily in R&D and strategic partnerships to sustain market leadership globally.

7. What future opportunities exist for market participants?

Future opportunities arise from combining stent‑grafts with drug‑eluting technologies, expanding indications to treat fusiform aneurysms, and leveraging AI‑driven imaging for patient selection. Partnerships with biotech firms developing bio‑resorbable scaffolds also promise differentiated product pipelines in.

8. How is technology influencing market dynamics?

Advances in micro‑fabrication and radiopaque materials have improved device flexibility and visibility, reducing procedural time. Integration of real‑time navigation systems and bioengineered coatings enhances safety, encouraging clinicians to prefer intracranial stent‑graft solutions over surgical alternatives.

9. What is the regulatory landscape for new entrants?

Regulators such as the FDA (via the 510(k) and PMA pathways) and the EU’s MDR impose rigorous pre‑market testing, clinical evidence, and post‑market surveillance. Compliance demands substantial investment, yet streamlined review programs for breakthrough devices can accelerate entry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Intracranial Stent Graft Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroPort; Medtronic plc; Stryker Corporation; Johnson & Johnson; Terumo Corporation; B. Braun Melsungen AG; Penumbra, Inc.; Canon Medical Systems Corporation; Acandis GmbH; Balt Extrusion
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options